← SynDRA
OSUGACESTAT
SynDRA canonical compound SYN0039448 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | APH1A | APH1B |
| Mechanism of action | gamma secretase inhibitor |
All known targets
Mechanisms of action (all sources)
- gamma-secretase inhibitor
Cross-references
Synonyms
- AL101
- BMS-906024
- AL-101
- BM-0018
- BM0018
- BMS 906024
- UNII-DRL23N424R
- DRL23N424R
- (2R,3S)-N1-((S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-2,3-bis(3,3,3-trifluoropropyl)succinamide
- SCHEMBL12543868
- DTXSID30161234
- CHEBI:131164
- ZINC100285156
- SB16893
- DB12006
- KB-145938
- Z-3229
- BMS-906024, >
- Butanediamide, N1-((3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-2,3-bis(3,3,3-trifluorophenyl)-, (2R,3S)-
- GSK4527226
- Bms 906024
- AL 101
- BMS906024
- RefChem:120754
- DTXCID8083725
- GS/pan-Notch Inhibitor AL101
- Osugacestat [USAN]
- AYOUDDAETNMCBW-GSHUGGBRSA-N
- Osugacestat [WHO-DD]
- OSUGACESTAT [INN]
- Osugacestat (USAN/INN)
- orb1707530
- SCHEMBL15622064
- SCHEMBL29412689
- EX-A9109
- MFCD24849414
- NSC780812
- WHO 11648
- AKOS040741390
Look up OSUGACESTAT in the interactive SynDRA portal →